Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Heike Bialleck"'
Autor:
Hubert Serve, Sebastian Wolf, Julius C. Enßle, Björn Steffen, Ivana von Metzler, Sebastian Scheich, Heike Bialleck, Sarah Weber, Erhard Seifried
Publikováno v:
Leukemia & Lymphoma. 62:3283-3287
Multiple myeloma (MM) is a malignant hematological disease with the clonal proliferation of plasma cells and accounts for approximately 10% of all malignant hematologic entities [1]. In eligible pa...
Autor:
Peter Reinhardt, Christian Seidl, Hubert Schrezenmeier, Heike Bialleck, Erhard Seifried, Arnd Schwebig, Sreekanth Gattu, Susanne Brauninger, Petra S. A. Becker, Beate Luxembourg, Halvard Bonig, Chrysanthi Tsamadou, Natalia Kaliakina, Pritibha Singh, Miriam Schulz, Joannis Mytilineos, M Wiesneth
Publikováno v:
Transfusion. 56:3055-3064
BACKGROUND Biosimilar granulocyte-colony-stimulating factors (G-CSFs) have been available in the European Union since 2008, and Sandoz' biosimilar filgrastim was approved in the United States in March 2015 for all of the reference product's indicatio
Autor:
Heike Bialleck, Gesine Bug, Kristin Thorausch, Miriam Schulz, Erhard Seifried, Ulrich Dünzinger, Halvard Bonig
Publikováno v:
Transfusion. 54:1622-1629
Background Unstimulated mononuclear cell (MNC) apheresis plays a role in the generation of donor lymphocytes (DLIs; healthy donors) and in extracorporeal photopheresis (ECP; patients). The new apheresis system Spectra Optia MNC has been shown in smal
Autor:
Beate Luxembourg, Halvard Bonig, Heike Bialleck, Kristin Thorausch, Miriam Schulz, Erhard Seifried
Publikováno v:
Transfusion. 53:3262-3268
Background Donor granulocyte concentrates are routinely administered to patients with granulocyte function defects or transient neutropenia and (risk of) bacterial or fungal exacerbations, despite lack of definitive clinical proof for patient-relevan
Publikováno v:
Vox Sanguinis. 105:47-53
Background and Objectives Therapeutic leucodepletion plays an established role in the initial treatment of patients with acute myeloid leukaemia (AML) and possibly other leukaemias presenting with leucostasis. Recently, a new leucodepletion technolog
Autor:
Halvard Bonig, Kristin Thorausch, Susanne Brauninger, Erhard Seifried, Heike Bialleck, Tom Felt
Publikováno v:
Transfusion. 52:1137-1145
BACKGROUND: Granulocyte–colony-stimulating factor–mobilized peripheral blood stem cells, collected by white blood cell apheresis, are used for more than 80% of allogeneic and most autologous hematopoietic stem cell transplantations. Optimal donor
Autor:
Carola Seifried, Heike Bialleck, Hubert Schrezenmeier, Marijke Weber, W. Kurt Roth, Erhard Seifried
Publikováno v:
Transfusion. 44:268-274
BACKGROUND: The prevalence of GB virus C (GBV-C)/HGV is high in individuals with parenteral risk factors. The frequency of GBV-C/HGV in blood donors is significantly lower, however it is still far above other parenterally transmitted viruses like HBV
Autor:
Michaele Duchscherer, Axel Thalhammer, Volkmar Jacobi, Heike Bialleck, Dieter Hoelzer, Stefan Klein, Stella Hermann, Hans Martin, Barbara Wassmann
Publikováno v:
British Journal of Haematology. 113:446-454
Leukaemic patients with advanced disease and severe fungal infections as well as older patients with substantial co-morbidity are usually excluded from conventional allotransplantation because of increased morbidity and mortality. We approached allog
Autor:
S. Tschauder, Erhard Seifried, S Zeuzem, W. K. Roth, H. Weber, S. Marx, D Waschk, Heike Bialleck
Publikováno v:
Transfusion. 37:651-656
Background Hepatitis G virus (HGV) and its strain variant, the GB agent (GBV-C) are independent isolates of a recently identified non-A through -E hepatitis virus. Prevalence in United States volunteer blood donors is 1.5 to 1.9 percent, but no data
Autor:
Miriam, Schulz, Heike, Bialleck, Kristin, Thorausch, Gesine, Bug, Ulrich, Dünzinger, Erhard, Seifried, Halvard, Bönig
Publikováno v:
Transfusion. 54(6)
Unstimulated mononuclear cell (MNC) apheresis plays a role in the generation of donor lymphocytes (DLIs; healthy donors) and in extracorporeal photopheresis (ECP; patients). The new apheresis system Spectra Optia MNC has been shown in small studies t